Yao-Foli Sekyema, MD
Nephrology · Danville, VANPI 1871545863
Payments from drug & device makers
Across 113 payments — averaging $61.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Bard Peripheral Vascular, Inc.$2K
- Philips North America LLC$1K
- Ardelyx, Inc.$486
- Merit Medical Systems Inc$350
- Vifor Pharma, Inc.$170
- plus $2K from 29 others
What the payments were for
- Speaking & faculty fees$3505%
- Travel & lodging$3,56051%
- Food & beverage$2,83741%
- Education$1222%
- Other$671%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 15 | $1,545 |
| Bard Peripheral Vascular, Inc. | 13 | $1,505 |
| Philips North America LLC | 5 | $1,339 |
| Ardelyx, Inc. | 1 | $486 |
| Merit Medical Systems Inc | 1 | $350 |
| Vifor Pharma, Inc. | 12 | $170 |
| Mallinckrodt Hospital Products Inc. | 9 | $166 |
| Boehringer Ingelheim | 2 | $138 |
| GSK | 4 | $123 |
| OPKO Pharmaceuticals, LLC | 3 | $115 |
| Akebia Therapeutics Inc | 3 | $101 |
| Amgen | 5 | $99 |
| Bayer | 3 | $85 |
| Travere Therapeutics, Inc. | 4 | $73 |
| E.r. Squibb & Sons, L.L.C. | 1 | $69 |
| Baxter Healthcare | 4 | $63 |
| AstraZeneca | 2 | $61 |
| Axonics, Inc. | 4 | $52 |
| Novartis | 2 | $47 |
| Welch Allyn | 2 | $35 |
| Dendreon Pharmaceuticals LLC | 1 | $34 |
| Outset Medical Inc | 1 | $29 |
| Calliditas Therapeutics US Inc. | 1 | $28 |
| Ambu Inc. | 2 | $27 |
| Accord Healthcare, Inc. | 2 | $26 |
| Cardiovascular Systems Inc. | 2 | $25 |
| AbbVie | 1 | $23 |
| Teleflex LLC | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
| Cormedix Inc. | 1 | $18 |
| ANI Pharmaceuticals, Inc. | 1 | $15 |
| Procept Biorobotics Corporation | 1 | $15 |
| Urovant Sciences Inc | 1 | $12 |
| Olympus America Inc. | 1 | $12 |
| Otsuka America Pharmaceutical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IGT D Peripheral$1,269
- ELLIPSYS VASCULAR ACCESS SYSTEM$1,103
- XPHOZAH 30 MG$486
- WRAPSODY Endovascular Stent Graft System$350
- JARDIANCE$122
How this compares
$6,936 in reported general payments places this provider in the 75th percentile of 298 nephrology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 23 | $116 |
| Prednisone | 26 | $31 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Danville
- Michael FredericksDanville$89K
- Olayiwola AyodejiHampton$7M
- Kiranjit DhillonNorfolk$4.5M
- Gaurav GuptaRichmond$2.1M
- Csaba KovesdySalem$1.5M
- Ramon MendezWoodbridge$1.5M
- Varagur Bala SubramanianAlexandria$957K
- Ahmadshah MirkhelFairfax$902K
- Renuka SothinathanFairfax$617K
- Steven LewinskiChesapeake$512K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.